Publications We at SKC have a profound knowledge of the health care industry and want to share our valuable experience with you.
Publication The EU HTA process should be considered … Interview in Market Access & Health Policy 01/2024 more
Publication How fast will the EU HTA child grow? Estimation of the number of procedures of the first years of implementation more
Publication Orphan vs. Non-Orphan Drugs in Germany Is there really a need for adjustment in the benefit assessment? more
Publication Gene therapies Gaps between theoretical assessment, practical benefit and reimbursement more
Publication Outcomes of Benefit Assessments of Orphan Drugs Without Orphan Designation in Germany more
Publication Patient Reported Outcome Measures (PROM) … PROM Are of Profound Importance for the Success of Health Technology Assessments in Oncologic … more
Strategy Report Act: Financial Stabilization of the SHI Strategic implications for market access in Germany more
Strategy Report Routine practice data collection for … Lessons learned from 2 years - Risk factors and strategic … more
Strategy Report The value of a digital operating room Lessons learned for a future-proof digitization approach in … more
Strategy Report Whitepaper: Registry requirements for … The G-BA specifies the procedure on the post-launch data … more
Strategy Report Successful market access for gene … New strategic challenges and possible solutions more
